Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 490

1.

What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators' Preferences in the SORCE Trial.

Lawrence NJ, Martin A, Davis ID, Troon S, Sengupta S, Hovey E, Coskinas X, Kaplan R, Smith B, Ritchie A, Meade A, Eisen T, Blinman P, Stockler MR.

Kidney Cancer. 2018 Aug 1;2(2):123-131. doi: 10.3233/KCA-180038.

2.

Patient-Centered Outcomes for Skin Cancer Management: Utilization of a Patient Delphi Process to Identify Important Treatment Themes.

Cartee TV, Alam M, Armbrecht ES, Behera A, Lawrence N, Bordeaux JS, Baum CL, Rossi A, Maher IA.

Dermatol Surg. 2019 Feb;45(2):246-253. doi: 10.1097/DSS.0000000000001756.

PMID:
30726197
3.

3D printed micro-scale force gauge arrays to improve human cardiac tissue maturation and enable high throughput drug testing.

Ma X, Dewan S, Liu J, Tang M, Miller KL, Yu C, Lawrence N, McCulloch AD, Chen S.

Acta Biomater. 2018 Dec 19. pii: S1742-7061(18)30751-7. doi: 10.1016/j.actbio.2018.12.026. [Epub ahead of print]

PMID:
30576862
4.

Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of Action.

Kumar M, Okombo J, Mambwe D, Taylor D, Lawrence N, Reader J, van der Watt M, Fontinha D, Sanches-Vaz M, Bezuidenhout BC, Lauterbach SB, Liebenberg D, Birkholtz LM, Coetzer TL, Prudêncio M, Egan TJ, Wittlin S, Chibale K.

ACS Infect Dis. 2019 Feb 8;5(2):303-315. doi: 10.1021/acsinfecdis.8b00272. Epub 2019 Jan 7.

PMID:
30525439
5.

The impact of autotrophic versus heterotrophic nutritional pathways on colony health and wound recovery in corals.

Burmester EM, Breef-Pilz A, Lawrence NF, Kaufman L, Finnerty JR, Rotjan RD.

Ecol Evol. 2018 Oct 18;8(22):10805-10816. doi: 10.1002/ece3.4531. eCollection 2018 Nov.

6.

Peptide-membrane interactions affect the inhibitory potency and selectivity of spider toxins ProTx-II and GpTx-1.

Lawrence N, Wu B, Ligutti J, Cheneval O, Agwa AJ, Benfield AH, Biswas K, Craik DJ, Miranda LP, Troeira Henriques S, Schroeder CI.

ACS Chem Biol. 2018 Dec 3. doi: 10.1021/acschembio.8b00989. [Epub ahead of print]

PMID:
30507158
7.

Antiplasmodial imidazopyridazines: structure-activity relationship studies lead to the identification of analogues with improved solubility and hERG profiles.

Cheuka PM, Lawrence N, Taylor D, Wittlin S, Chibale K.

Medchemcomm. 2018 Sep 6;9(10):1733-1745. doi: 10.1039/c8md00382c. eCollection 2018 Oct 1.

PMID:
30429978
8.

A randomised controlled trial examining the efficacy of smoking-related response inhibition training in smokers: a study protocol.

Staiger PK, Hayden MJ, Guo K, Hughes LK, Bos J, Lawrence NS.

BMC Public Health. 2018 Nov 3;18(1):1226. doi: 10.1186/s12889-018-6109-y.

9.

Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria".

Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Gonzàlez Cabrera D, Nchinda AT, de Kock C, Wiesner L, Denti P, Waterson D, Blasco B, Leroy D, Witty MJ, Donini C, Duffy J, Wittlin S, White KL, Charman SA, Jiménez-Díaz MB, Angulo-Barturen I, Herreros E, Gamo FJ, Rochford R, Mancama D, Coetzer TL, van der Watt ME, Reader J, Birkholtz LM, Marsh KC, Solapure SM, Burke JE, McPhail JA, Vanaerschot M, Fidock DA, Fish PV, Siegl P, Smith DA, Wirjanata G, Noviyanti R, Price RN, Marfurt J, Silue KD, Street LJ, Chibale K.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01941-18. doi: 10.1128/AAC.01941-18. Print 2018 Nov. No abstract available.

10.

Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite Strains.

Le Manach C, Paquet T, Wicht K, Nchinda AT, Brunschwig C, Njoroge M, Gibhard L, Taylor D, Lawrence N, Wittlin S, Eyermann CJ, Basarab GS, Duffy J, Fish PV, Street LJ, Chibale K.

J Med Chem. 2018 Oct 25;61(20):9371-9385. doi: 10.1021/acs.jmedchem.8b01333. Epub 2018 Oct 16.

PMID:
30256636
11.

Investigating Sulfoxide-to-Sulfone Conversion as a Prodrug Strategy for a Phosphatidylinositol 4-Kinase Inhibitor in a Humanized Mouse Model of Malaria.

Gibhard L, Njoroge M, Paquet T, Brunschwig C, Taylor D, Lawrence N, Abay E, Wittlin S, Wiesner L, Street LJ, Chibale K, Basarab GS.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e00261-18. doi: 10.1128/AAC.00261-18. Print 2018 Dec.

PMID:
30249687
12.

Targeting the BRD4-HOXB13 Coregulated Transcriptional Networks with Bromodomain-Kinase Inhibitors to Suppress Metastatic Castration-Resistant Prostate Cancer.

Nerlakanti N, Yao J, Nguyen DT, Patel AK, Eroshkin AM, Lawrence HR, Ayaz M, Kuenzi BM, Agarwal N, Chen Y, Gunawan S, Karim RM, Berndt N, Puskas J, Magliocco AM, Coppola D, Dhillon J, Zhang J, Shymalagovindarajan S, Rix U, Kim Y, Perera R, Lawrence NJ, Schonbrunn E, Mahajan K.

Mol Cancer Ther. 2018 Dec;17(12):2796-2810. doi: 10.1158/1535-7163.MCT-18-0602. Epub 2018 Sep 21.

PMID:
30242092
13.

Ventilation perfusion single photon emission computed tomography: Referral practices and diagnosis of acute pulmonary embolism in the quaternary clinical setting.

Lawrence NC, Kyle S.

J Med Imaging Radiat Oncol. 2018 Dec;62(6):777-780. doi: 10.1111/1754-9485.12803. Epub 2018 Sep 20.

PMID:
30238629
14.

Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours.

Lawrence NJ, Chan H, Toner G, Stockler MR, Martin A, Yip S, Wong N, Yeung A, Mazhar D, Pashankar F, Frazier L, McDermott R, Walker R, Tan H, Davis ID, Grimison P; ANZUP.

BMC Cancer. 2018 Aug 29;18(1):854. doi: 10.1186/s12885-018-4745-3.

15.

Defining the Determinants of Specificity of Plasmodium Proteasome Inhibitors.

Yoo E, Stokes BH, de Jong H, Vanaerschot M, Kumar T, Lawrence N, Njoroge M, Garcia A, Van der Westhuyzen R, Momper JD, Ng CL, Fidock DA, Bogyo M.

J Am Chem Soc. 2018 Sep 12;140(36):11424-11437. doi: 10.1021/jacs.8b06656. Epub 2018 Aug 29.

PMID:
30107725
16.

3D-Printing of Functional Biomedical Microdevices via Light- and Extrusion-Based Approaches.

Hwang HH, Zhu W, Victorine G, Lawrence N, Chen S.

Small Methods. 2018 Feb 13;2(2). pii: 1700277. doi: 10.1002/smtd.201700277. Epub 2017 Dec 19.

17.

Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane Disruption.

Lawrence N, Dennis ASM, Lehane AM, Ehmann A, Harvey PJ, Benfield AH, Cheneval O, Henriques ST, Craik DJ, McMorran BJ.

Cell Chem Biol. 2018 Sep 20;25(9):1140-1150.e5. doi: 10.1016/j.chembiol.2018.06.009. Epub 2018 Jul 19.

PMID:
30033131
18.

UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.

Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Cabrera DG, Nchinda AT, de Kock C, Wiesner L, Denti P, Waterson D, Blasco B, Leroy D, Witty MJ, Donini C, Duffy J, Wittlin S, White KL, Charman SA, Jiménez-Díaz MB, Angulo-Barturen I, Herreros E, Gamo FJ, Rochford R, Mancama D, Coetzer TL, van der Watt ME, Reader J, Birkholtz LM, Marsh KC, Solapure SM, Burke JE, McPhail JA, Vanaerschot M, Fidock DA, Fish PV, Siegl P, Smith DA, Wirjanata G, Noviyanti R, Price RN, Marfurt J, Silue KD, Street LJ, Chibale K.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00012-18. doi: 10.1128/AAC.00012-18. Print 2018 Sep. Erratum in: Antimicrob Agents Chemother. 2018 Oct 24;62(11):.

PMID:
29941635
19.

3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling.

Ma X, Liu J, Zhu W, Tang M, Lawrence N, Yu C, Gou M, Chen S.

Adv Drug Deliv Rev. 2018 Jul;132:235-251. doi: 10.1016/j.addr.2018.06.011. Epub 2018 Jun 21. Review.

PMID:
29935988
20.

Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of Malaria.

Kandepedu N, Gonzàlez Cabrera D, Eedubilli S, Taylor D, Brunschwig C, Gibhard L, Njoroge M, Lawrence N, Paquet T, Eyermann CJ, Spangenberg T, Basarab GS, Street LJ, Chibale K.

J Med Chem. 2018 Jul 12;61(13):5692-5703. doi: 10.1021/acs.jmedchem.8b00648. Epub 2018 Jun 27.

PMID:
29889526
21.

Cosmetic Dermatology Training During Residency: Outcomes of a Resident-Reported Survey.

Champlain A, Reserva J, Webb K, Griffin D, Moy L, Joyce C, Glaser DA, Lawrence N, Lee KC, Antonovich DD, Duffy DM, Kim J, Ozog D, Sobanko J, Alam M, Tung RC.

Dermatol Surg. 2018 Sep;44(9):1216-1219. doi: 10.1097/DSS.0000000000001557.

PMID:
29781906
22.

Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes.

Agwa AJ, Peigneur S, Chow CY, Lawrence N, Craik DJ, Tytgat J, King GF, Henriques ST, Schroeder CI.

J Biol Chem. 2018 Jun 8;293(23):9041-9052. doi: 10.1074/jbc.RA118.002553. Epub 2018 Apr 27.

PMID:
29703751
23.

Identification of Fast-Acting 2,6-Disubstituted Imidazopyridines That Are Efficacious in the in Vivo Humanized Plasmodium falciparum NODscidIL2Rγ null Mouse Model of Malaria.

Nchinda AT, Le Manach C, Paquet T, Gonzàlez Cabrera D, Wicht KJ, Brunschwig C, Njoroge M, Abay E, Taylor D, Lawrence N, Wittlin S, Jiménez-Díaz MB, Santos Martínez M, Ferrer S, Angulo-Barturen I, Lafuente-Monasterio MJ, Duffy J, Burrows J, Street LJ, Chibale K.

J Med Chem. 2018 May 10;61(9):4213-4227. doi: 10.1021/acs.jmedchem.8b00382. Epub 2018 Apr 27.

PMID:
29665687
24.

Empathic responses are reduced to competitive but not non-competitive outgroups.

Richins MT, Barreto M, Karl A, Lawrence N.

Soc Neurosci. 2018 Apr 18:1-14. doi: 10.1080/17470919.2018.1463927. [Epub ahead of print]

PMID:
29633906
25.

Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099.

Sun X, Ren Y, Gunawan S, Teng P, Chen Z, Lawrence HR, Cai J, Lawrence NJ, Wu J.

Leukemia. 2018 May;32(5):1246-1249. doi: 10.1038/s41375-018-0020-5. Epub 2018 Jan 30. No abstract available.

26.

Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.

Akuffo AA, Alontaga AY, Metcalf R, Beatty MS, Becker A, McDaniel JM, Hesterberg RS, Goodheart WE, Gunawan S, Ayaz M, Yang Y, Karim MR, Orobello ME, Daniel K, Guida W, Yoder JA, Rajadhyaksha AM, Schönbrunn E, Lawrence HR, Lawrence NJ, Epling-Burnette PK.

J Biol Chem. 2018 Apr 20;293(16):6187-6200. doi: 10.1074/jbc.M117.816868. Epub 2018 Feb 15.

PMID:
29449372
27.

Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells.

Mahajan NP, Coppola D, Kim J, Lawrence HR, Lawrence NJ, Mahajan K.

Sci Rep. 2018 Jan 31;8(1):1954. doi: 10.1038/s41598-018-20172-z.

28.

The Emergence of Organizing Structure in Conceptual Representation.

Lake BM, Lawrence ND, Tenenbaum JB.

Cogn Sci. 2018 Jun;42 Suppl 3:809-832. doi: 10.1111/cogs.12580. Epub 2018 Jan 9.

PMID:
29315735
29.

Attrition from Web-Based Cognitive Testing: A Repeated Measures Comparison of Gamification Techniques.

Lumsden J, Skinner A, Coyle D, Lawrence N, Munafo M.

J Med Internet Res. 2017 Nov 22;19(11):e395. doi: 10.2196/jmir.8473.

30.

Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.

Wilson CR, Gessner RK, Moosa A, Seldon R, Warner DF, Mizrahi V, Soares de Melo C, Simelane SB, Nchinda A, Abay E, Taylor D, Njoroge M, Brunschwig C, Lawrence N, Boshoff HIM, Barry CE 3rd, Sirgel FA, van Helden P, Harris CJ, Gordon R, Ghidelli-Disse S, Pflaumer H, Boesche M, Drewes G, Sanz O, Santos G, Rebollo-Lopez MJ, Urones B, Selenski C, Lafuente-Monasterio MJ, Axtman M, Lelièvre J, Ballell L, Mueller R, Street LJ, Ghorpade SR, Chibale K.

J Med Chem. 2017 Dec 28;60(24):10118-10134. doi: 10.1021/acs.jmedchem.7b01347. Epub 2017 Dec 7.

31.

To Go or Not to Go: A Proof of Concept Study Testing Food-Specific Inhibition Training for Women with Eating and Weight Disorders.

Turton R, Nazar BP, Burgess EE, Lawrence NS, Cardi V, Treasure J, Hirsch CR.

Eur Eat Disord Rev. 2018 Jan;26(1):11-21. doi: 10.1002/erv.2566. Epub 2017 Nov 3.

PMID:
29098749
32.

Population structure and genetic diversity of Bromus tectorum within the small grain production region of the Pacific Northwest.

Lawrence NC, Hauvermale AL, Dhingra A, Burke IC.

Ecol Evol. 2017 Sep 7;7(20):8316-8328. doi: 10.1002/ece3.3386. eCollection 2017 Oct.

33.

Efficient inference for sparse latent variable models of transcriptional regulation.

Dai Z, Iqbal M, Lawrence ND, Rattray M.

Bioinformatics. 2017 Dec 1;33(23):3776-3783. doi: 10.1093/bioinformatics/btx508.

34.

Male Body Contouring.

Coleman KM, Lawrence N.

Dermatol Surg. 2017 Nov;43 Suppl 2:S188-S193. doi: 10.1097/DSS.0000000000001319. Review.

PMID:
28858933
35.

Fourier transform large amplitude alternating current voltammetry investigations of the split wave phenomenon in electrocatalytic mechanisms.

Song P, Ma H, Meng L, Wang Y, Nguyen HV, Lawrence NS, Fisher AC.

Phys Chem Chem Phys. 2017 Sep 13;19(35):24304-24315. doi: 10.1039/c7cp03510a.

PMID:
28849830
36.

Corrigendum to "Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7" [Biochim. Biophys. Acta 1859(5) (2017) 835-844].

Agwa AJ, Lawrence N, Deplazes E, Cheneval O, Chen RM, Craik DJ, Schroeder CI, Henriques ST.

Biochim Biophys Acta Biomembr. 2017 Nov;1859(11):2277. doi: 10.1016/j.bbamem.2017.08.008. Epub 2017 Aug 25. No abstract available.

37.

Analysis of Wait Times and Impact of Real-Time Surveys on Patient Satisfaction.

Pena SM, Lawrence N.

Dermatol Surg. 2017 Oct;43(10):1288-1291. doi: 10.1097/DSS.0000000000001232.

PMID:
28796658
38.

Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties.

Troeira Henriques S, Lawrence N, Chaousis S, Ravipati AS, Cheneval O, Benfield AH, Elliott AG, Kavanagh AM, Cooper MA, Chan LY, Huang YH, Craik DJ.

ACS Chem Biol. 2017 Sep 15;12(9):2324-2334. doi: 10.1021/acschembio.7b00459. Epub 2017 Aug 8.

PMID:
28741926
39.

ACK1/TNK2 Regulates Histone H4 Tyr88-phosphorylation and AR Gene Expression in Castration-Resistant Prostate Cancer.

Mahajan K, Malla P, Lawrence HR, Chen Z, Kumar-Sinha C, Malik R, Shukla S, Kim J, Coppola D, Lawrence NJ, Mahajan NP.

Cancer Cell. 2017 Jun 12;31(6):790-803.e8. doi: 10.1016/j.ccell.2017.05.003.

40.

Cognitive training as a potential treatment for overweight and obesity: A critical review of the evidence.

Jones A, Hardman CA, Lawrence N, Field M.

Appetite. 2018 May 1;124:50-67. doi: 10.1016/j.appet.2017.05.032. Epub 2017 May 22. Review.

41.

Pilot test of a novel food response and attention training treatment for obesity: Brain imaging data suggest actions shape valuation.

Stice E, Yokum S, Veling H, Kemps E, Lawrence NS.

Behav Res Ther. 2017 Jul;94:60-70. doi: 10.1016/j.brat.2017.04.007. Epub 2017 Apr 19.

42.

ASDS Guidelines Task Force: Consensus Recommendations Regarding the Safety of Lasers, Dermabrasion, Chemical Peels, Energy Devices, and Skin Surgery During and After Isotretinoin Use.

Waldman A, Bolotin D, Arndt KA, Dover JS, Geronemus RG, Chapas A, Iyengar S, Kilmer SL, Krakowski AC, Lawrence N, Prather HB, Rohrer TE, Schlosser BJ, Kim JYS, Shumaker PR, Spring LK, Alam M.

Dermatol Surg. 2017 Oct;43(10):1249-1262. doi: 10.1097/DSS.0000000000001166.

PMID:
28498204
43.

From cookies to carrots; the effect of inhibitory control training on children's snack selections.

Porter L, Bailey-Jones C, Priudokaite G, Allen S, Wood K, Stiles K, Parvin O, Javaid M, Verbruggen F, Lawrence NS.

Appetite. 2018 May 1;124:111-123. doi: 10.1016/j.appet.2017.05.010. Epub 2017 May 4.

44.

Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.

Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, Versace A, Bilderbeck AC, Uhlmann A, Mwangi B, Krämer B, Overs B, Hartberg CB, Abé C, Dima D, Grotegerd D, Sprooten E, Bøen E, Jimenez E, Howells FM, Delvecchio G, Temmingh H, Starke J, Almeida JRC, Goikolea JM, Houenou J, Beard LM, Rauer L, Abramovic L, Bonnin M, Ponteduro MF, Keil M, Rive MM, Yao N, Yalin N, Najt P, Rosa PG, Redlich R, Trost S, Hagenaars S, Fears SC, Alonso-Lana S, van Erp TGM, Nickson T, Chaim-Avancini TM, Meier TB, Elvsåshagen T, Haukvik UK, Lee WH, Schene AH, Lloyd AJ, Young AH, Nugent A, Dale AM, Pfennig A, McIntosh AM, Lafer B, Baune BT, Ekman CJ, Zarate CA, Bearden CE, Henry C, Simhandl C, McDonald C, Bourne C, Stein DJ, Wolf DH, Cannon DM, Glahn DC, Veltman DJ, Pomarol-Clotet E, Vieta E, Canales-Rodriguez EJ, Nery FG, Duran FLS, Busatto GF, Roberts G, Pearlson GD, Goodwin GM, Kugel H, Whalley HC, Ruhe HG, Soares JC, Fullerton JM, Rybakowski JK, Savitz J, Chaim KT, Fatjó-Vilas M, Soeiro-de-Souza MG, Boks MP, Zanetti MV, Otaduy MCG, Schaufelberger MS, Alda M, Ingvar M, Phillips ML, Kempton MJ, Bauer M, Landén M, Lawrence NS, van Haren NEM, Horn NR, Freimer NB, Gruber O, Schofield PR, Mitchell PB, Kahn RS, Lenroot R, Machado-Vieira R, Ophoff RA, Sarró S, Frangou S, Satterthwaite TD, Hajek T, Dannlowski U, Malt UF, Arolt V, Gattaz WF, Drevets WC, Caseras X, Agartz I, Thompson PM, Andreassen OA.

Mol Psychiatry. 2018 Apr;23(4):932-942. doi: 10.1038/mp.2017.73. Epub 2017 May 2.

45.

BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned.

Hayne D, Stockler M, McCombie SP, Lawrence N, Martin A, Sengupta S, Davis ID.

BJU Int. 2017 May;119 Suppl 5:55-57. doi: 10.1111/bju.13873. Review. No abstract available.

46.

Intestinal Transport Characteristics and Metabolism of C-Glucosyl Dihydrochalcone, Aspalathin.

Bowles S, Joubert E, de Beer D, Louw J, Brunschwig C, Njoroge M, Lawrence N, Wiesner L, Chibale K, Muller C.

Molecules. 2017 Mar 30;22(4). pii: E554. doi: 10.3390/molecules22040554.

47.

What Is Trained During Food Go/No-Go Training? A Review Focusing on Mechanisms and a Research Agenda.

Veling H, Lawrence NS, Chen Z, van Koningsbruggen GM, Holland RW.

Curr Addict Rep. 2017;4(1):35-41. doi: 10.1007/s40429-017-0131-5. Epub 2017 Feb 22. Review.

48.

A Retrospective Case-Matched Cost Comparison of Surgical Treatment of Melanoma and Nonmelanoma Skin Cancer in the Outpatient Versus Operating Room Setting.

Johnson RP, Butala N, Alam M, Lawrence N.

Dermatol Surg. 2017 Jul;43(7):897-901. doi: 10.1097/DSS.0000000000001069.

PMID:
28346253
49.

Single-cell RNA-seq and computational analysis using temporal mixture modelling resolves Th1/Tfh fate bifurcation in malaria.

Lönnberg T, Svensson V, James KR, Fernandez-Ruiz D, Sebina I, Montandon R, Soon MS, Fogg LG, Nair AS, Liligeto U, Stubbington MJ, Ly LH, Bagger FO, Zwiessele M, Lawrence ND, Souza-Fonseca-Guimaraes F, Bunn PT, Engwerda CR, Heath WR, Billker O, Stegle O, Haque A, Teichmann SA.

Sci Immunol. 2017 Mar 3;2(9). pii: eaal2192. doi: 10.1126/sciimmunol.aal2192. Erratum in: Sci Immunol. 2018 Mar 9;3(21):.

50.

Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics.

Ember SW, Lambert QT, Berndt N, Gunawan S, Ayaz M, Tauro M, Zhu JY, Cranfill PJ, Greninger P, Lynch CC, Benes CH, Lawrence HR, Reuther GW, Lawrence NJ, Schönbrunn E.

Mol Cancer Ther. 2017 Jun;16(6):1054-1067. doi: 10.1158/1535-7163.MCT-16-0568-T. Epub 2017 Mar 23.

Supplemental Content

Loading ...
Support Center